Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
49.6M
-
Number of holders
-
101
-
Total 13F shares, excl. options
-
45.6M
-
Shares change
-
+11.1M
-
Total reported value, excl. options
-
$876M
-
Value change
-
+$221M
-
Put/Call ratio
-
5.52
-
Number of buys
-
59
-
Number of sells
-
-30
-
Price
-
$19.23
Significant Holders of Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) as of Q3 2025
114 filings reported holding ORKA - Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2025.
Oruka Therapeutics, Inc. - Common Stock, par value $0.001 per share (ORKA) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.6M shares
of 49.6M outstanding shares and own 91.86% of the company stock.
Largest 10 shareholders include FMR LLC (7.26M shares), VR ADVISER, LLC (4.15M shares), Fairmount Funds Management LLC (3.71M shares), VIKING GLOBAL INVESTORS LP (2.67M shares), Deep Track Capital, LP (2.65M shares), BlackRock, Inc. (2.2M shares), RTW INVESTMENTS, LP (1.95M shares), VANGUARD GROUP INC (1.78M shares), Commodore Capital LP (1.75M shares), and BRAIDWELL LP (1.38M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.